Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models

BACKGROUND: With the 2020 target year for elimination of lymphatic filariasis (LF) approaching, there is an urgent need to assess how long mass drug administration (MDA) programs with annual ivermectin + albendazole (IA) or diethylcarbamazine + albendazole (DA) would still have to be continued, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolk, Wilma A, Prada, Joaquin M, Smith, Morgan E, Kontoroupis, Periklis, de Vos, Anneke S, Touloupou, Panayiota, Irvine, Michael A, Brown, Paul, Subramanian, Swaminathan, Kloek, Marielle, Michael, E, Hollingsworth, T Deirdre, de Vlas, Sake J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982795/
https://www.ncbi.nlm.nih.gov/pubmed/29860286
http://dx.doi.org/10.1093/cid/ciy003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982795/
https://www.ncbi.nlm.nih.gov/pubmed/29860286
http://dx.doi.org/10.1093/cid/ciy003

Ejemplares similares